Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 28841418.
- Also identified by DOI 10.1016/j.cell.2017.07.025 and PMC identifier 5589211.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
We present an exceptional case of a patient with high-grade serous ovarian cancer, treated with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions with concomitant progression of other lesions during a treatment-free period. Using immunogenomic approaches, we found that progressing metastases were characterized by immune cell exclusion, whereas regressing and stable metastases were infiltrated by CD8<sup>+</sup> and CD4<sup>+</sup> T cells and exhibited oligoclonal expansion of specific T cell subsets. We also detected CD8<sup>+</sup> T cell reactivity against predicted neoepitopes after isolation of cells from a blood sample taken almost 3 years after the tumors were resected. These findings suggest that multiple distinct tumor immune microenvironments co-exist within a single individual and may explain in part the heterogeneous fates of metastatic lesions often observed in the clinic post-therapy. VIDEO ABSTRACT.
Medical subject headings
- Cystadenocarcinoma, Serous
- Neoplasm Metastasis
- Ovarian Neoplasms
- Tumor Microenvironment